January 2023
Headline Example Text
Historic event description text to input here, it can be have up to 10 lines
About NanoPhoria
NanoPhoria is a preclinical-stage biotech company pioneering the next generation of cardiovascular treatments through an innovative inhaled, nano-in-micro delivery platform. Our mission is to transform the way therapeutic peptides and RNAs are delivered, enabling precise, tissue-directed treatment for complex cardiovascular conditions.
At the heart of our delivery technology is a proprietary nano-in-micro platform built on inorganic calcium phosphate nanoparticles embedded in highly respirable microparticles. CaP nanoparticles represent a versatile, biomimetic nanocarrier that can be loaded or surface-decorated with biologics. This non-viral, scalable system is designed for inhalation and other administration routes, offering a safe and effective alternative for advanced drug delivery.
Our lead product, NP-MP1, is an inhalable nano-in-micro formulation delivering a first-in-class calcium channel modulator peptide for the treatment of Heart Failure with Reduced Ejection Fraction (HFrEF), which is a chronic syndrome impacting millions worldwide.
By combining cutting-edge nanotechnology with therapeutic innovation, NanoPhoria is redefining what’s possible in cardiovascular care.
TIMELINE
2023
2022
May 2022
Another headline example text on two lines to compare
Historic event description text to input here, it can be have up to 10 lines but shorter lengths
January 2022
Another headline example text on two lines to compare
Historic event description text to input here, it can be have up to 10 lines but shorter lengths are recommended as a general guide